Sign In
Buy PRTA
$8.83
-0.410 (-4.44%)
At Close: Jul 13, 2026
Prothena Announces Presentations on Two Programs from its Alzheimer's Disease Portfolio at CTAD 2020
08:30am, Wednesday, 04'th Nov 2020
DUBLIN, Ireland, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with expertise in protein dysregulation and a diverse pipeline of investigation
Prothena to Report Third Quarter 2020 Financial Results on November 4
04:05pm, Wednesday, 28'th Oct 2020
DUBLIN, Ireland, Oct. 28, 2020 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with expertise in protein dysregulation and a diverse pipeline of investigation
